Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $300,979 - $436,200
12,567 New
12,567 $314,000
Q2 2022

Aug 15, 2022

SELL
$21.39 - $35.9 $252,209 - $423,296
-11,791 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$24.84 - $36.12 $276,295 - $401,762
-11,123 Reduced 48.54%
11,791 $402,000
Q4 2021

Feb 14, 2022

BUY
$33.38 - $59.25 $388,242 - $689,136
11,631 Added 103.08%
22,914 $798,000
Q3 2021

Nov 15, 2021

BUY
$53.75 - $76.55 $321,747 - $458,228
5,986 Added 113.01%
11,283 $617,000
Q2 2021

Aug 16, 2021

BUY
$59.02 - $78.8 $312,628 - $417,403
5,297 New
5,297 $401,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.22B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.